Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Feb 13;10:781–790. doi: 10.2147/OTT.S111920

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Yao et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Kaplan–Meier survival curve for overall survival according to each immunohistochemical staining group and different clinical factors.

Notes: (A and B) shows the overall survival curves after surgery according to ZEB-1 and E-cadherin expression; (C) displays the 5-year overall survival rates were significantly poorer in the ZEB-1 positive and loss of E-cadherin expression group than in other expression groups; (D–F) shows that patients with moderate/poor differentiation, lymph node metastasis and recurrence have worse prognosis.

Abbreviation: ZEB-1, zinc-finger E-box binding homeobox 1.